Fate Therapeutics Inc. (FATE) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Fate Therapeutics Inc.

NASDAQ: FATE · Real-Time Price · USD
1.21
0.00 (0.00%)
At close: Oct 03, 2025, 3:59 PM
1.23
1.65%
After-hours: Oct 03, 2025, 07:56 PM EDT

Fate Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
36.06M 41.87M 61.33M 133.58M
Short-Term Investments
243.01M 273.31M 374.89M 482.33M
Long-Term Investments
27.66M 980K 4.94M 100.66M
Other Long-Term Assets
10.24M 15.19M 132.48M 116.66M
Receivables
3.54M 1.83M 38.48M 8.68M
Inventory
n/a n/a n/a n/a
Other Current Assets
9.3M 14.54M 27.37M n/a
Total Current Assets
291.91M 331.54M 502.07M 633.41M
Property-Plant & Equipment
110.89M 158.51M 66.07M 70.72M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
148.78M 174.68M 203.49M 288.04M
Total Assets
440.69M 506.22M 705.56M 921.46M
Account Payables
9.37M 4.72M 8.27M 8.61M
Deferred Revenue
393K 685K 42.23M 21.48M
Short-Term Debt
7.42M 6.18M 5.63M 5.58M
Other Current Liabilities
4.22M 10.78M 34.41M 21.68M
Total Current Liabilities
38.52M 39.09M 114.05M 81.28M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
5.6M 1.35M 3.86M 24.97M
Total Long-Term Liabilities
83.45M 98.71M 107.57M 161.33M
Total Liabilities
121.97M 137.8M 221.62M 242.62M
Total Debt
85.27M 103.54M 109.34M 114.82M
Book Value
318.73M 368.42M 483.94M 678.84M
Book Value Per Share
2.80 3.74 5.00 7.16
Common Stock
114K 99K 97K 96K
Retained Earnings
-1.4B -1.21B -1.05B -769.08M
Comprehensive Income
268K 15K -1.85M -762K
Shareholders Equity
318.73M 368.42M 483.94M 678.84M
Total Investments
270.67M 274.29M 379.84M 582.99M